Annovis BioFRA:07X -4.06%38 Forward Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus rates FRA:07X with a GF Score™ of 38/100. The stock has 1 warning sign investors should review. Among 145 Biotechnology companies, Annovis Bio ranks worse than 689654.48% on this metric.
As of today (2026-06-28), the Forward Annual Dividend Yield of Annovis Bio is 0.00%.
As of today (2026-06-28), the Trailing Annual Dividend Yield of Annovis Bio is 0.00%.
FRA:07X's Forward Dividend Yield % is not ranked *
in the Biotechnology industry.
Industry Median: 1.57 * Ranked among companies with meaningful Forward Dividend Yield % only.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Annovis Bio (FRA:07X) Forward Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Annovis Bio Forward Dividend Yield % Related Terms
FRA:07X vs CSBR, HYFT, GANX: Forward Dividend Yield % Comparison
For the Biotechnology subindustry, Annovis Bio's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Annovis Bio Forward Dividend Yield % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Annovis Bio's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Annovis Bio's Forward Dividend Yield % falls into.
What does a Forward Dividend Yield % of 0.00% mean?
Annovis Bio (FRA:07X) has a Forward Dividend Yield % of 0.00% as of Jun. 28, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Annovis Bio and its competitors. According to the industry distribution chart, Annovis Bio ranks #999999 out of 145 companies in the Biotechnology industry.
Is Annovis Bio's Forward Dividend Yield % too high?
Annovis Bio's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Annovis Bio ranks #999999 out of 145 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Annovis Bio has a GF Score™ of 38/100, reflecting its overall financial health beyond just this single metric.
How does Annovis Bio's Forward Dividend Yield % compare to CSBR and HYFT?
According to the Biotechnology industry distribution chart, Annovis Bio ranks #999999 out of 145 companies for Forward Dividend Yield %. This places Annovis Bio in the lower half of its industry. The industry median Forward Dividend Yield % is 1.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Biotechnology company?
The median Forward Dividend Yield % among Biotechnology companies is 1.57, based on 145 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Annovis Bio and its competitors. For the Biotechnology industry, the median Forward Dividend Yield % is 1.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Annovis Bio's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Annovis Bio stock overvalued right now?
Annovis Bio (FRA:07X) has a current Forward Dividend Yield % of 0.00%. The current Forward Dividend Yield % is 0.00%. Annovis Bio's overall GF Score™ is 38/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Annovis Bio (FRA:07X), the current Forward Dividend Yield % is 0.00% as of Jun. 28, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Annovis Bio Inc, a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company's flagship candidate, buntanetap, is in clinical trials for the treatment of Alzheimer's disease, Parkinson's disease, and Lewy body dementia. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer's disease and dementia.
38GF Score
Get the complete analysis for FRA:07X
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:07X has been successfully added to your 